Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDF
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Pioglitazone (Actos) and rosiglitazone (Avandia) authority wording changedPioglitazone (Actos) and rosiglitazone (Avandia) authority wording changed
Published 2006-08-01 00:00:00
The wording of the Pharmaceutical Benefits Scheme (PBS) requirements for pioglitazone and rosiglitazone changed on 1 August 2006. The changes are intended to simplify the listings. The authority requirements for the glitazones have not changed.
As shown in the table below, both pioglitazone and rosiglitazone are PBS listed (authority required) for dual oral therapy with metformin or a sulfonylurea, and in combination with insulin. Only rosiglitazone is listed for triple oral therapy with metformin and a sulfonylurea.
To be eligible for initiation of a PBS-subsidised glitazone, patients must have a glycosylated haemoglobin (HbA1c) level > 7%. The HbA1c level, which must have been measured within the 4 months preceding the application, must be provided. A provision has been added to the authority listing to exempt from this requirement patients in whom HbA1c testing is likely to be inaccurate (for example, those with thalassaemia minor). For these patients, results of blood glucose monitoring over 2 weeks, during which more than 20% of results showed a blood glucose concentration above 10 mmol/L, will be accepted.
PBS-listed indications of the glitazones
| Pioglitazone (Actos) |
Rosiglitazone (Avandia) |
|
|---|---|---|
| Monotherapy |  |
|
| Dual oral therapy (with metformin or a sulfonylurea) |
 |
|
| Triple oral therapy (with metformin and a sulfonylurea) |
|
|
| Combination with insulin | |
|
Date published: 2006-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
